UNSPSC 51285900: Antibacterial amines

This classification denotes antibacterials derived from ammonia by substituting organic radicals for the hydrogens, substances called amines.

UNSPSC 51285900 Antibacterial amines is a Class code encompassing antimicrobial chemical compounds and pharmaceutical products that state and local governments procure for public health, emergency response, and medical supply applications. Recent solicitations show state and local buyers acquiring naloxone and drug deactivation systems for community health initiatives, generic pharmaceuticals and over-the-counter products for multi-state cooperative purchasing networks, and medical and first aid supplies for fire and rescue divisions. The issuing bodies span county health departments, state health and human services agencies, municipal fire departments, and multi-state cooperative purchasing alliances; Seminole County, Florida and the City of Tampa have posted opportunities under this code in the past twelve months, while the Minnesota Multistate Cooperative Purchasing Alliance and Texas Health and Human Services Commission represent broader regional and statewide procurement activity.

Recent activity clusters in Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The City of Tampa released an IFB (26P00145, due March 13, 2026) for medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and consumables for the Tampa Fire Department Rescue Division, estimated at $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Department of Administration issued an RFP (S1070000015802, due March 26, 2026) through MMCAP to establish multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers with product availability by May 15, 2026. Texas Health and Human Services Commission posted an RFI (HHS0017013, due April 3, 2026) soliciting vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information on direct contracting models outside traditional pharmacy benefit manager and group purchasing organization arrangements.